These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31103607)

  • 1. Current research trends and challenges in tissue engineering for mending broken hearts.
    Qasim M; Arunkumar P; Powell HM; Khan M
    Life Sci; 2019 Jul; 229():233-250. PubMed ID: 31103607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial tissue engineering and heart muscle repair.
    Karikkineth BC; Zimmermann WH
    Curr Pharm Biotechnol; 2013; 14(1):4-11. PubMed ID: 23092254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell engineering for treatment of heart diseases: potentials and challenges.
    Li SC; Wang L; Jiang H; Acevedo J; Chang AC; Loudon WG
    Cell Biol Int; 2009 Mar; 33(3):255-67. PubMed ID: 19084605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
    Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fiber Scaffold Patterning for Mending Hearts: 3D Organization Bringing the Next Step.
    Kristen M; Ainsworth MJ; Chirico N; van der Ven CFT; Doevendans PA; Sluijter JPG; Malda J; van Mil A; Castilho M
    Adv Healthc Mater; 2020 Jan; 9(1):e1900775. PubMed ID: 31603288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of injectable hydrogels for cardiac stem cell therapy and tissue engineering.
    Alagarsamy KN; Yan W; Srivastava A; Desiderio V; Dhingra S
    Rev Cardiovasc Med; 2019 Dec; 20(4):221-230. PubMed ID: 31912713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D bioprinted functional and contractile cardiac tissue constructs.
    Wang Z; Lee SJ; Cheng HJ; Yoo JJ; Atala A
    Acta Biomater; 2018 Apr; 70():48-56. PubMed ID: 29452273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue engineering and stem cell therapy for myocardial repair.
    Gu Y; Yu J; Lum LG; Lee RJ
    Front Biosci; 2007 Sep; 12():5157-65. PubMed ID: 17569637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomaterials for Stem Cell Therapy for Cardiac Disease.
    Kim H; Kim SL; Choi YH; Ahn YH; Hwang NS
    Adv Exp Med Biol; 2018; 1064():181-193. PubMed ID: 30471033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomaterial strategies for alleviation of myocardial infarction.
    Venugopal JR; Prabhakaran MP; Mukherjee S; Ravichandran R; Dan K; Ramakrishna S
    J R Soc Interface; 2012 Jan; 9(66):1-19. PubMed ID: 21900319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cells: new cell source for myocardial constructs tissue engineering.
    Wu KH; Cui B; Yu CT; Liu YL
    Med Hypotheses; 2006; 67(6):1326-9. PubMed ID: 16814940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascularisation to improve translational potential of tissue engineering systems for cardiac repair.
    Dilley RJ; Morrison WA
    Int J Biochem Cell Biol; 2014 Nov; 56():38-46. PubMed ID: 25449260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-Enabled Approaches for Stem Cell-Based Cardiac Tissue Engineering.
    Kharaziha M; Memic A; Akbari M; Brafman DA; Nikkhah M
    Adv Healthc Mater; 2016 Jul; 5(13):1533-53. PubMed ID: 27199266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical Engineering of Cell Therapy for Heart Diseases.
    Li Z; Hu S; Cheng K
    Acc Chem Res; 2019 Jun; 52(6):1687-1696. PubMed ID: 31125198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
    Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
    Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Situ Preconditioning of Human Mesenchymal Stem Cells Elicits Comprehensive Cardiac Repair Following Myocardial Infarction.
    Sim WS; Park BW; Ban K; Park HJ
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic Mesenchymal Stem Cells and Biomaterials: The Perfect Match for Cardiac Repair?
    Perez-Estenaga I; Prosper F; Pelacho B
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations.
    Liu Z; Mikrani R; Zubair HM; Taleb A; Naveed M; Baig MMFA; Zhang Q; Li C; Habib M; Cui X; Sembatya KR; Lei H; Zhou X
    Eur J Pharmacol; 2020 Jun; 876():173049. PubMed ID: 32142771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional scaffold-free microtissues engineered for cardiac repair.
    Patino-Guerrero A; Veldhuizen J; Zhu W; Migrino RQ; Nikkhah M
    J Mater Chem B; 2020 Sep; 8(34):7571-7590. PubMed ID: 32724973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable cardiac tissue engineering for the treatment of myocardial infarction.
    Wang H; Zhou J; Liu Z; Wang C
    J Cell Mol Med; 2010 May; 14(5):1044-55. PubMed ID: 20193036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.